Akata Saha

The University of Texas MD Anderson Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy”.

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy

Cell Reports(2024)10.1016/j.celrep.2024.114875

N/A

0.539DataRank · unranked

14 citations

Alexander S. Shavkunov, Qi Miao, Akata Saha, Tomoyuki Minowa, Martina Molgora +12 more

Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.20.570816

N/A

0DataRank · unranked

3 citations

Alexander S. Shavkunov, Qi Miao, Akata Saha, Charmelle D. Williams, Anna M. Highsmith +7 more